Indicated for contraception, Slynd is a progestogen-only pill (POP) offering drospirenone without oestrogen.1,2
Adverse events should be reported. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Exeltis UK Limited on 01494 411775 or by email to uk.medinfo@exeltis.com
| Pack size3 | 3 x (24+4) tablets |
| Price | £14.70 |
| PIP | 425-9867 |
| GTIN | 08437018658930 |
Slynd 4mg film-coated tablets Summary of Product Characteristics
FSRH Clinical Guidance progestogen-only pills. July 2023
BNF. Available at: https://bnf.nice.org.uk/drugs/drospirenone/medicinal-forms/ (Accessed October 2024)
Find out more about Slynd® on the product website: www.slynd.co.uk
Company info
